Human monoclonal antibody targeting TNFR2 for cancer immunotherapy Grant US-11389480-B2 United States of America 19 Jul 2022
HUMAN MONOCLONAL ANTIBODY TARGETING TNFER2 FOR CANCER IMMUNOTHERAPY Application WO-2018213064-A1 World Intellectual Property Organisation (WIPO) 22 Nov 2018